Dr Carolyn Taylor
Letters after your name
Clinical Research Fellow and Honorary Consultant Oncologist
Carolyn Taylor is a consultant clinical oncologist and researcher into the late effects of cancer treatments. She studied medicine at Oxford University. Her clinical training was in general medicine and then clinical oncology. She gained Fellowship of the Royal College of Radiologists in 2004.
Since then she has worked as a clinical research fellow at the Clinical Trial Service Unit, doing research alongside clinical work. She completed her DPhil on the risk of heart disease after breast cancer radiotherapy in 2008. She now continues to research the late effects of cancer treatments and works in the clinic with childhood cancer survivors.
Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer.
Boekel NB. et al, (2018), Br j cancer, 119, 408 - 418
Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015.
Aznar MC. et al, (2018), Radiother oncol, 126, 148 - 154
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet oncol, 19, 27 - 39
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Pan H. et al, (2017), N engl j med, 377, 1836 - 1846
Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.
Taylor C. et al, (2017), J clin oncol, 35, 1641 - 1649